Expired Study
This study is not currently recruiting Study Participants on ClinicalConnection.com. If you would like to find active studies please search for clinical trials.

Raritan, New Jersey 08869


Purpose:

The objective of the Eprex (erythropoietin) Treatment Program is to provide erythropoietin for the treatment of anemia in AIDS patients.


Criteria:

Exclusion Criteria Co-existing Condition: Patients with the following are excluded: - Life expectancy < 3 months. - = or < grade 4 performance score. - AIDS-related dementia. - Uncontrolled hypertension. - Acute symptomatic opportunistic infection or other AIDS-defining illness. Patients with the following are excluded: - Life expectancy < 3 months. - = or < grade 4 performance score. - AIDS-related dementia. - Uncontrolled hypertension. - Acute symptomatic opportunistic infection or other AIDS-defining illness. Patients must have: - A clinical diagnosis of AIDS. - Hematocrit < 30 percent. - Endogenous serum erythropoietin level = or < 500 U/ml. - A life expectancy = or > 3 months. - > Grade 4 performance score.


NCT ID:

NCT00002022


Primary Contact:

N/A


Backup Contact:

N/A


Location Contact:

Raritan, New Jersey 08869
United States



There is no listed contact information for this specific location.

Site Status: N/A


Data Source: ClinicalTrials.gov

Date Processed: September 23, 2017

Modifications to this listing: Only selected fields are shown, please use the link below to view all information about this clinical trial.


Click to view Full Listing

This study is not currently recruiting Study Participants on ClinicalConnection.com. The form below is not enabled.